Transmembrane Protein 230 Mediates a Poly(ADP-ribose) Polymerase-1-Linked Apoptosis

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Mutations in the transmembrane protein 230 (TMEM230) gene are linked to autosomal dominant Parkinson's disease (PD).
• The precise functions of TMEM230 and its role in PD pathogenesis remain unclear.
• Understanding TMEM230's cellular mechanisms is crucial for elucidating PD pathology.

Purpose of the Study:

• To investigate the cellular functions of TMEM230, particularly its role in cell death.
• To explore the mechanism by which TMEM230 variants contribute to Parkinson's disease.
• To identify potential therapeutic targets by understanding TMEM230-mediated cell death pathways.

Main Methods:

• Ectopic expression of wild-type (WT) and PD-linked mutant TMEM230 isoform II constructs in cultured cells.
• Assessment of cell viability, apoptosis markers (caspase 3/7, PARP1 cleavage), mitochondrial reactive oxygen species (ROS) levels, and cellular ATP content.
• Treatment with ROS scavenger N-acetylcysteine (NAC) and caspase inhibitor Z-VAD-FMK to evaluate their protective effects.

Main Results:

• Expression of both WT and mutant TMEM230 induced significant apoptotic cell death.
• Mutant TMEM230 variants exhibited greater cell toxicity compared to WT TMEM230.
• TMEM230 expression increased ROS production, decreased ATP levels, activated caspase 3/7, and led to PARP1 cleavage.
• NAC and Z-VAD-FMK treatments attenuated TMEM230-induced apoptosis, indicating involvement of ROS and caspases.
• TMEM230 mediated cell death through a PARP1-dependent pathway.

Conclusions:

• TMEM230 plays a significant role in inducing apoptotic cell death.
• The findings reveal a novel TMEM230-mediated cell death pathway involving PARP1.
• This TMEM230-induced cell death mechanism provides new insights into Parkinson's disease pathogenesis.